Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 39% ± 14% | |
peripheral blood | 18 studies | 44% ± 12% | |
intestine | 11 studies | 26% ± 10% | |
kidney | 8 studies | 32% ± 13% | |
uterus | 5 studies | 46% ± 15% | |
prostate | 5 studies | 32% ± 12% | |
lymph node | 5 studies | 35% ± 17% | |
brain | 5 studies | 27% ± 6% | |
breast | 4 studies | 41% ± 7% | |
bone marrow | 3 studies | 40% ± 13% | |
eye | 3 studies | 31% ± 15% | |
thymus | 3 studies | 22% ± 5% | |
placenta | 3 studies | 26% ± 4% | |
liver | 3 studies | 32% ± 6% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 10717.29 | 245 / 245 | 100% | 161.67 | 501 / 502 |
lung | 100% | 20204.35 | 578 / 578 | 100% | 140.82 | 1152 / 1155 |
thymus | 100% | 8705.77 | 653 / 653 | 100% | 148.09 | 603 / 605 |
stomach | 100% | 5729.74 | 359 / 359 | 100% | 96.50 | 285 / 286 |
breast | 100% | 9273.32 | 459 / 459 | 100% | 165.72 | 1113 / 1118 |
uterus | 100% | 10349.70 | 170 / 170 | 99% | 141.99 | 456 / 459 |
kidney | 100% | 12578.61 | 89 / 89 | 99% | 138.63 | 893 / 901 |
intestine | 99% | 7127.99 | 961 / 966 | 99% | 99.47 | 524 / 527 |
bladder | 100% | 9933.24 | 21 / 21 | 98% | 103.88 | 493 / 504 |
esophagus | 99% | 4693.25 | 1424 / 1445 | 99% | 96.74 | 181 / 183 |
ovary | 100% | 7058.58 | 180 / 180 | 96% | 76.23 | 413 / 430 |
skin | 97% | 6206.01 | 1749 / 1809 | 99% | 138.64 | 467 / 472 |
liver | 99% | 5770.07 | 223 / 226 | 96% | 90.35 | 390 / 406 |
pancreas | 79% | 2534.02 | 259 / 328 | 98% | 145.06 | 174 / 178 |
adrenal gland | 95% | 3584.32 | 244 / 258 | 70% | 34.52 | 162 / 230 |
brain | 69% | 2898.60 | 1832 / 2642 | 90% | 67.90 | 638 / 705 |
adipose | 100% | 10227.10 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 117.10 | 80 / 80 |
peripheral blood | 100% | 52726.94 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 12950.72 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 69.79 | 1 / 1 |
blood vessel | 100% | 10808.48 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 98% | 140.70 | 44 / 45 |
lymph node | 0% | 0 | 0 / 0 | 97% | 222.10 | 28 / 29 |
heart | 88% | 3945.67 | 757 / 861 | 0% | 0 | 0 / 0 |
muscle | 63% | 1857.58 | 503 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0010935 | Biological process | regulation of macrophage cytokine production |
GO_1901223 | Biological process | negative regulation of non-canonical NF-kappaB signal transduction |
GO_0043123 | Biological process | positive regulation of canonical NF-kappaB signal transduction |
GO_0001817 | Biological process | regulation of cytokine production |
GO_0071222 | Biological process | cellular response to lipopolysaccharide |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0005886 | Cellular component | plasma membrane |
GO_0098560 | Cellular component | cytoplasmic side of late endosome membrane |
GO_0009898 | Cellular component | cytoplasmic side of plasma membrane |
GO_0098559 | Cellular component | cytoplasmic side of early endosome membrane |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0098574 | Cellular component | cytoplasmic side of lysosomal membrane |
GO_0000139 | Cellular component | Golgi membrane |
GO_0043231 | Cellular component | intracellular membrane-bounded organelle |
GO_0005765 | Cellular component | lysosomal membrane |
GO_0005634 | Cellular component | nucleus |
GO_0000978 | Molecular function | RNA polymerase II cis-regulatory region sequence-specific DNA binding |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0042802 | Molecular function | identical protein binding |
GO_0050699 | Molecular function | WW domain binding |
GO_0008270 | Molecular function | zinc ion binding |
GO_0005515 | Molecular function | protein binding |
Gene name | LITAF |
Protein name | Lipopolysaccharide induced TNF factor Lipopolysaccharide-induced tumor necrosis factor-alpha factor (LPS-induced TNF-alpha factor) (Small integral membrane protein of lysosome/late endosome) (p53-induced gene 7 protein) |
Synonyms | SIMPLE PIG7 |
Description | FUNCTION: Plays a role in endosomal protein trafficking and in targeting proteins for lysosomal degradation . Plays a role in targeting endocytosed EGFR and ERGG3 for lysosomal degradation, and thereby helps down-regulate downstream signaling cascades . Helps recruit the ESCRT complex components TSG101, HGS and STAM to cytoplasmic membranes . Probably plays a role in regulating protein degradation via its interaction with NEDD4 . May also contribute to the regulation of gene expression in the nucleus . Binds DNA (in vitro) and may play a synergistic role with STAT6 in the nucleus in regulating the expression of various cytokines . May regulate the expression of numerous cytokines, such as TNF, CCL2, CCL5, CXCL1, IL1A and IL10 . . |
Accessions | I3L2T1 ENST00000622633.5 [Q99732-1] Q99732 ENST00000571277.1 ENST00000576334.1 I3L2T6 ENST00000570798.5 I3L1I9 ENST00000571627.5 ENST00000570904.5 [Q99732-1] ENST00000571459.5 I3L1P1 ENST00000574701.5 ENST00000574703.5 ENST00000573332.5 I3L329 I3L133 I3L409 ENST00000574848.5 I3L1R0 A0A0G2JLC4 ENST00000413364.6 [Q99732-3] ENST00000576036.5 [Q99732-1] I3L1H3 ENST00000571976.1 I3L3U8 ENST00000574763.5 [Q99732-1] ENST00000572255.5 ENST00000571688.5 [Q99732-1] I3L2E2 ENST00000339430.9 [Q99732-1] ENST00000575426.1 |